In vivo voltammetric detection of neuropeptides with micro carbon fiber biosensors: possible selective detection of somatostatin

Recent advances in the biosensing of neurotransmitters: material and method overviews towards the biomedical analysis of psychiatric disorders

Neurotransmitters are the most important messengers of the nervous system, and any changes in their balances and activities can cause serious neurological, psychiatric and cognitive disorders such as schizophrenia, Alzheimer's disease and Parkinson's disease.

Central [CNS] and Peripheral [Gastric Tissue] Selective Monitoring of Somatostatin (SRIF) with Micro-Sensor and Voltammetry in Rats: Influence of Growth Factors (GH, EGF)

Somatostatin (SRIF) is widely distributed throughout the body, and regulates the endocrine system via interactions with various hormones, including the pituitary growth hormone, the thyroid stimulating hormone and the majority of the hormones of the gastrointestinal tract. SRIF is present in the central nervous system (CNS), where it affects rates of neurotransmission, and is also reported to be active in the intestinal tract, with evidence that stressed rats present a significant decrease in antral somatostatin-like immunoreactivity (SLI). Analysis of SRIF has mainly been carried out by means of radioimmunoassay methods. Here, we propose the use of an electrochemical method, such as voltammetry, applied with carbon-based sensors and, in particular, the combination of differential pulse voltammetry with treated carbon fiber micro electrodes (DPV-µCFE) to facilitate the analysis of such peptidergic electro active hormones in the rat striatum and gastric tissue; the effect of growth hormone (GH) and epidermal growth factor (EGF), in particular, upon the SRIF signal has been studied in such tissues.

Technologies for continuous glucose monitoring: current problems and future promises

Devices for continuous glucose monitoring (CGM) are currently a major focus of research in the area of diabetes management. It is envisioned that such devices will have the ability to alert a diabetes patient (or the parent or medical care giver of a diabetes patient) of impending hypoglycemic/hyperglycemic events and thereby enable the patient to avoid extreme hypoglycemic/hyperglycemic excursions as well as minimize deviations outside the normal glucose range, thus preventing both life-threatening events and the debilitating complications associated with diabetes. It is anticipated that CGM devices will utilize constant feedback of analytical information from a glucose sensor to activate an insulin delivery pump, thereby ultimately realizing the concept of an artificial pancreas. Depending on whether the CGM device penetrates/breaks the skin and/or the sample is measured extracorporeally, these devices can be categorized as totally invasive, minimally invasive, and noninvasive. In addition, CGM devices are further classified according to the transduction mechanisms used for glucose sensing (i.e., electrochemical, optical, and piezoelectric). However, at present, most of these technologies are plagued by a variety of issues that affect their accuracy and long-term performance. This article presents a critical comparison of existing CGM technologies, highlighting critical issues of device accuracy, foreign body response, calibration, and miniaturization. An outlook on future developments with an emphasis on long-term reliability and performance is also presented.

Emerging synergy between nanotechnology and implantable biosensors: a review

The development of implantable biosensors for continuous monitoring of metabolites is an area of sustained scientific and technological interests. On the other hand, nanotechnology, a discipline which deals with the properties of materials at the nanoscale, is developing as a potent tool to enhance the performance of these biosensors. This article reviews the current state of implantable biosensors, highlighting the synergy between nanotechnology and sensor performance. Emphasis is placed on the electrochemical method of detection in light of its widespread usage and substantial nanotechnology based improvements in various aspects of electrochemical biosensor performance. Finally, issues regarding toxicity and biocompatibility of nanomaterials, along with future prospects for the application of nanotechnology in implantable biosensors, are discussed.

Correlative morphometric and electrochemical measurements of serotonin content in earthworm muscles

Distribution of serotonin (5-HT) content of nervous fibers in both the somatic and the visceral muscle of Eisenia fetida have been investigated using immunocytochemical staining and voltammetric measurements. The somatic muscles in the body wall are richer innervated with serotoninergic fibers than the visceral ones in the pharynx and gizzard. The relative density of immunopositive fibers in the circular muscle layer of the body wall was found to be 2.73% while in the prostomium it was 1.02%. In the case of the muscle in pharynx 1.12% and in gizzard 1.28% density values were found. Differential Pulse Voltammetric (DPV) measurements with carbon fiber electrodes in the above mentioned muscle layers gave 272.5 nA, 135.0 nA, 122.5 nA, 137.5 nA peak heights, respectively. In the statistical analysis T-test was used at a confidence level of 95% (p<0.05). DPV current peak (i(p)) values reflect clearly the 5-HT concentration differences. Significant correlation was found between the innervation density and the i(p) values recorded in different areas. The i(p) values recorded at different times in different locations are determined by instantaneous serotonin concentration of the living tissue. As far as we know this is the first report using in vivo voltammetry investigating serotonin content in earthworm, E. fetida.

In vivo voltammetry: from wire to wireless measurements

A novel telemetric system based on either differential pulse voltammetry (DPV) or direct current amperometry (DCA) by using a diffused infrared transmission channel is presented. Unlike similar pre-existing instruments based on infrared transmission, the present system works on a single-way communication, thus avoiding problems related to cross-talking between two-way channels. The infrared channel is also immune from electromagnetic interferences from the surrounding environment. Further advancement is the development of an original miniaturised system (dimension 1cm x 1.2 cm x 0.5 cm) with reduced weight (5-6 g), suitable for affixing to the rat head and allowing real time telemetric monitoring using DCA sampling of neurotransmitters such as dopamine or serotonin every 100 ms. The set-up is based on a transmitter (TX) circuit mounted on the animal's head and connected to the electrodes inserted into its brain. The TX circuit generates the proper electrical signals for DPV or DCA, collects the electrical response of the brain and transmits it, via an infrared channel, to a receiving station (RX) interfaced with a personal computer. The PC performs the sampling and elaboration of polarographic traces in a flexible and programmable way.

Amino acid neurotransmitters: separation approaches and diagnostic value

Amino acids in the central nervous system can be divided into non-neurotransmitter or neurotransmitter depending on their function. The measurement of these small molecules in brain tissue and extracellular fluid has been used to develop effective treatment strategies for neuropsychiatric and neurodegenerative diseases and for the diagnosis of such pathologies. Here we describe the separation and detection techniques that have been used for the measurement of amino acids at trace levels in brain tissue and dialysates. An overview of the function of amino acid transmitters in the brain is given. In addition, the type of sampling techniques that are used for the determination of amino acid levels in the brain is described.

In vivo voltammetry and concomitant electrophysiology at a single micro-biosensor to analyse ischaemia, depression and drug dependence

Electrochemical methods such as voltammetry can be used to understand patho-physiological mechanisms of action and, therefore, develop therapeutic approaches. In particular, voltammetry with treated micro-biosensors (carbon fibre micro-electrodes, mCFE) has been used to study models of (1) ischaemia; (2) drug dependence, and in particular craving; (3) depression. In addition, in studies (1) and (3) concomitant in vivo voltammetric and electrophysiological analysis has been performed by means of the same mCFE. Original data concerning ascorbate release in ischaemia, peptidergic activity during craving for drugs of abuse and concomitant voltammetric and electrophysiological changes of the serotonergic system in rats submitted to forced swimming test or to pharmacological treatment with the selective serotonin reuptake inhibitor fluoxetine are shown and discussed.

Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands

In the brain, cholecystokinin (CCK) has been described to act as a central neurotransmitter or neuromodulator involved in functions such as food consumption, stress and anxiety. Recently, the CCK system has been involved in drug dependence phenomena and proposed to be correlated to a putative state of 'drug preferring' phenotype within free choice tests. CCK exerts its action in the CNS through at least two different G-protein coupled high affinity receptors, CCK1 and CCK2. Various selective CCK receptor agonists and antagonists have been synthesised. In particular, L-364,718 has been demonstrated to be a potent and selective CCK1 receptor antagonist, whereas L-365,260 is a potent and selective CCK2 receptor antagonist. More recently, GV150013 has been reported to be a highly selective CCK2 receptor antagonist. This paper reviews the putative role of the CCK system within drug dependence phenomena. In particular, it analyses the relationship between central CCK activity and the exhibition of spontaneous preference for drugs of abuse, such as cocaine or alcohol. The potential therapeutic role for CCK receptor antagonists is also discussed.

Middle cerebral artery occlusion alters neurotransmitter activities in ipsilateral and contralateral rat brain regions: an ex vivo voltammetric study

Differential pulse voltammetry with treated carbon fibre micro-electrodes has been successfully employed in in vivo analysis of neurotransmitter release and metabolism. This methodology has been now applied to ex vivo preparations (brain slices) in order to study diverse neurotransmitter activities in various brain regions ipsilateral and controlateral to a middle cerebral artery (MCA) occlusion performed in anaesthetised adult male rats. Data demonstrated that significant changes of voltammetric ascorbic acid levels related to the ischaemic state were monitored within the ipsilateral to MCA occlusion frontal cortex, striatum, nucleus accumbens and hippocampus which were the brain area studied. Furthermore, it appeared that voltammetric catecholaminergic and 5-hydroxy indolaminergic values measured within the nucleus accumbens controlateral to MCA occlusion differ significantly from the results monitored with the same technique in brain slices obtained from sham rats. In various studies, the brain regions contralateral to MCA occlusion are generally considered as control areas, however, the present data suggest that the nucleus accumbens contralateral to the MCA occlusion side is specifically affected by the ischaemic state.

Concomitant in vivo electrophysiological and voltammetric analysis indicate that ascorbic acid is a biochemical index of early ischaemia

A number of in vitro studies or in vivo cortical microdialysis measurements have observed that changes in the levels of ascorbic acid (AA), uric acid (UA), tryptophan (TRY), indoles and other compounds may be biochemical markers of cerebral ischaemic damages following occlusion of the rat middle cerebral artery (MCAO). The aim of the present work was to study the influence of early ischaemia upon presynaptic and postsynaptic activities in the cerebral cortex of rats. These activities have been studied by means of electrophysiological and electro-biochemical (voltammetric) measurements performed concomitantly every 5 min and applied with the same biosensor. The biosensor was inserted in the cerebral cortex of anaesthetised adult male rats which were then submitted to focal ischaemia via MCAO. Since changes in electrophysiological activity are considered marker of rise of ischaemia, the choice of simultaneous electrophysiological and electrochemical (voltammetric) analysis could allow the observation of specific biochemical(s) correlation(s) with the initial phase of ischaemia. The data obtained indicated that electrophysiological and voltammetric changes can be monitored simultaneously in the same brain region (i.e. effected by MCAO) by means of a single biosensor with an improved time resolution when compared with previous biochemical in vivo studies. In addition, a high correlation was observed between MCAO reduced functional responses of the neurons monitored by electrophysiology and increased levels of AA measured by voltammetry. This original observation suggests that AA is a biochemical marker of the very early stages of focal ischaemia and could be a useful tool for the evaluation of initial ischaemic damage.

Carbon fibre micro-electrode and in vitro or in brain slices voltammetric measurement of ascorbate, catechol and indole oxidation signals: influence of temperature and physiological media

Carbon fibre micro-electrodes have been used to determine the influence of temperature and physiological media on the oxidation potential value of three carboxylic acids of physiological interest such as ascorbate (AA), 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindolacetic acid (5HIAA). Standard calibrations at room temperature (18-20 degrees C) in phosphate buffered saline (PBS, pH 7.4), in Krebs (pH 7.4) or in artificial cerebral spinal fluid (ACSF, pH 7.4) have been compared with calibrations performed at 37 degrees C under 95% oxygen, 5% carbon dioxide. Ex vivo experiments were then performed with the electrode inserted in the striatum of rat brain slices maintained in ACSF at 37 degrees C under 95% oxygen, 5% carbon dioxide. The results obtained from both in vitro and ex vivo experimentation indicate that the oxidation potential of peak 2 (DOPAC) is highly sensitive to changes in temperature and medium. Therefore the extrapolation from in vitro electrode calibrations performed in PBS at room temperature to ex vivo (brain slices) and possibly in vivo measurements of DOPAC oxidation should be reconsidered.

Simultaneous, selective detection of catecholaminergic and indolaminergic signals using cyclic voltammetry with treated micro-sensor

Selective and simultaneous voltammetric analysis of catechols and indoles in vivo and in vitro has until now been feasible only by means of 'slow' scanning methods (scan speed in tens of seconds) such as differential pulse (DPV) and differential normal pulse voltammetry in conjunction with electrically and/or chemically treated carbon-fiber micro-electrodes (mCFE). Faster electrochemical techniques, such as chronoamperometry and cyclic voltammetry (CV), allow more rapid (seconds or fractions of a second) and frequent measurements of these chemicals. However, these methods show poor sensitivity and selectivity in the presence of different electroactive compounds with similar oxidation potentials. In order to analyze whether the lack of sensitivity and selectivity of the fast voltammetric methods results from the rapidity of the measurement or from the use of untreated sensors, the methods of CV (scan speed: 1000 mV/s) and DPV (scan speed: 10 mV/s) have been applied with either untreated or electrically treated mCFE to analyze the in vitro oxidation potential and current values of DA and 5-HT. When associated with untreated mCFE, neither method was able to separate and selectively detect the two compounds dissolved together in an inert vehicle; the voltammogram recorded resulted in a single broad oxidation signal. In contrast, when these techniques were performed with electrically treated mCFE, oxidation signals for DA (peak A) and 5-HT (peak B) were monitored simultaneously at approximately + 65 mV and + 240 mV, with DPV respectively, and at + 120 mV and + 300 mV with CV, respectively. Additionally, CV with treated mCFE on anesthetized rats, simultaneously monitored two striatal signals at approximately + 100 mV and + 300 mV. The oxidation values (Em) and current levels (nA) of these peaks remained stable during control recordings. The current levels were selectively increased by peripheral injection of fluphenazine (DA antagonist) or of 5-hydroxytryptophan (precursor of serotonin). The chemical nature of these two peaks may therefore be considered catecholaminergic and indolaminergic, respectively. Hence, this report provides the first evidence for the feasibility of concomitant in vitro analysis of DA and 5-HT using a rapid scanning method such as CV. In addition, the values of current level (nA) obtained with CV-mCFE for DA and 5-HT are comparable to those monitored with DPV-mCFE, supporting the view that treatment of the sensor is a key point for increasing the selectivity and the sensitivity of these voltammetric techniques. The feasibility of using CV with electrically treated mCFE for fast in vivo analysis of catechol and indole activities is also demonstrated.

Carbon fibre micro-electrodes for concomitant in vivo electrophysiological and voltammetric measurements: no reciprocal influences

Differential pulse voltammetry and more recently cyclic voltammetry have been successfully used to monitor basal levels of endogenous chemicals by means of treated carbon fibre microbiosensors inserted in specific brain regions. In this study, feasibility of concomitant in vivo recordings of stable electrophysiological signals and basal ascorbate, catecholaminergic and indolaminergic voltammetric peaks at the same cerebral site by means of a single electrically treated carbon fibre micro electrode (microbiosensor) is presented. The results indicate that these two independent techniques can be combined in vivo at a single electrode, and that voltammetric measurements of unstimulated levels of extracellular compounds do not alter concomitant basal cell firing for a period long enough (more than 6 h) to allow pharmacological manipulations.

Short-range differential pulse voltammetry for fast, selective analysis of basal levels of cerebral compounds in vivo

Differential pulse voltammetry (DPV) with pretreated biosensors (carbon fibre microelectrodes (mCFE), 10-30 microns diameter) allows selective in vivo measurement of basal endogenous levels of dopamine (DA), serotonin (5-HT), their metabolites (dihydroxyphenylacetic acid, DOPAC; 5-hydroxyindoleacetic acid, 5-HIAA), and neuropeptides. We have now modified DPV in order to reduce the time of analysis from tens of seconds to 1-2 s without losing selectivity. We call this newly reported method short-range differential pulse voltammetry (SRDPV). Simply, while in DPV the complete oxidation peak is recorded, SRDPV measures only the top of each oxidation peak. For example, to monitor peak 2 which corresponds to the in vivo oxidation of extracellular DOPAC and occurs at approximately +85 +/- 10 mV, the initial (Ei) and final (Ef) potentials applied with DPV were -100 mV and +200 mV, respectively, while they were +75 mV (Ei) and +95 mV (Ef) with SRDPV. At the typical scan range of 10 mV.s-1, the effective time of measurement was 30 s for DPV and 2 s for SRDPV. A similar procedure was performed to analyze peak 3 (5-HIAA, occurring at +230 +/- 11 mV) with Ei + 50 mV and Ef + 350 mV for DPV, or +220 mV and +240 mV for SRDPV. DPV and SRDPV were compared in vitro by quantitating DOPAC and 5-HIAA in solutions of increasing concentrations (chosen on the basis of the suggested in vivo content of these two compounds). Data indicated that similar sensitivity and selectivity were obtained with both methods at all concentrations, supporting the applicability of SRDPV for in vitro studies. In vivo experiments were performed in anesthetized adult male rats prepared for voltammetry by inserting the electrically pretreated biosensor (mCFE) into the striatum. DPV measurements were performed automatically every 3-5 min and were alternated every 10-20 min with a sequence of 5-10 SRDPV scans performed every 10-30 s. Subsequent pharmacological or electrical manipulations of the two biogenic amine systems studied were monitored by alternate use of DPV and SRDPV. The data presented support the capability of SRDPV with pretreated biosensors to measure in vivo electroactive compounds with selectivity and sensitivity comparable to that of DPV, but with improved time resolution.